Rozov Yadin bought ORMP
January 4, 2024 · Form 4 insider transaction
Rozov Yadin bought 8,820 shares of Oramed Pharmaceuticals Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,820
Price
N/A
Total value
N/A
InsiderRozov Yadin
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 4, 2024
Filing dateJanuary 8, 2024
Shares owned after155,320
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of 2,205 on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.